MedPath

Study on Immunomodulatory Action of Suvarna Prashana on Recurrent Upper Respiratory Tract Infection in Children.

Phase 2
Registration Number
CTRI/2021/06/034161
Lead Sponsor
CA DR Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Children of age group of 1 to 5 years of either sex will be selected.

2. Children having recurrent episodes of recurrent URTI will be selected.

Exclusion Criteria

1. Children having age less than 01 yrs and more than 5 years will be excluded.

2. Children having congenital anomalies, chronic pulmonary disease like pulmonary tuberculosis, chronic lung disease, in error of metabolism, chronic hematological disorders and chronic gastro intestinal disorders etc will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief from Recurrent Upper Respiratory tract infection( Relief sign and symptoms)Timepoint: 45 Days
Secondary Outcome Measures
NameTimeMethod
Increase immunityTimepoint: 45 Days
© Copyright 2025. All Rights Reserved by MedPath